1
|
Gao Q, Liu MQ, Li JX, Wang Y, Zhang Y, Zhu H. Sex differences in stress-induced hyperalgesia and its mechanisms. J Neurosci Res 2024; 102:e25266. [PMID: 38284853 DOI: 10.1002/jnr.25266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 09/26/2023] [Accepted: 10/08/2023] [Indexed: 01/30/2024]
Abstract
Chronic stress induces a variety of physiological and/or psychological abnormalities, including hyperalgesia. Researchers have discovered sex differences in the prevalence of stress-induced hyperalgesia (SIH) in recent years. Sex differences may be one of the reasons for the heterogeneity of susceptibility to stress-related diseases. In this review, the potential mechanisms of sex differences in SIH are discussed, such as hypothalamus-pituitary-adrenal axis responses, regulation of sex hormones, and immune system responses.
Collapse
Affiliation(s)
- Qiang Gao
- Department of Physiology, Harbin Medical University, Harbin, P. R. China
| | - Mei-Qi Liu
- Department of Physiology, Harbin Medical University, Harbin, P. R. China
| | - Jia-Xin Li
- Department of Physiology, Harbin Medical University, Harbin, P. R. China
| | - Yi Wang
- Biotechnology Experimental Teaching Center, Harbin Medical University, Harbin, P. R. China
| | - Ying Zhang
- Department of Physiology, Harbin Medical University, Harbin, P. R. China
| | - Hui Zhu
- Department of Physiology, Harbin Medical University, Harbin, P. R. China
| |
Collapse
|
2
|
Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Sadowski B. Differential role of specific cardiovascular neuropeptides in pain regulation: Relevance to cardiovascular diseases. Neuropeptides 2020; 81:102046. [PMID: 32284215 DOI: 10.1016/j.npep.2020.102046] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/17/2019] [Revised: 03/27/2020] [Accepted: 03/29/2020] [Indexed: 12/11/2022]
Abstract
In many instances, the perception of pain is disproportionate to the strength of the algesic stimulus. Excessive or inadequate pain sensation is frequently observed in cardiovascular diseases, especially in coronary ischemia. The mechanisms responsible for individual differences in the perception of cardiovascular pain are not well recognized. Cardiovascular disorders may provoke pain in multiple ways engaging molecules released locally in the heart due to tissue ischemia, inflammation or cellular stress, and through neurogenic and endocrine mechanisms brought into action by hemodynamic disturbances. Cardiovascular neuropeptides, namely angiotensin II (Ang II), angiotensin-(1-7) [Ang-(1-7)], vasopressin, oxytocin, and orexins belong to this group. Although participation of these peptides in the regulation of circulation and pain has been firmly established, their mutual interaction in the regulation of pain in cardiovascular diseases has not been profoundly analyzed. In the present review we discuss the regulation of the release, and mechanisms of the central and systemic actions of these peptides on the cardiovascular system in the context of their central and peripheral nociceptive (Ang II) and antinociceptive [Ang-(1-7), vasopressin, oxytocin, orexins] properties. We also consider the possibility that they may play a significant role in the modulation of pain in cardiovascular diseases. The rationale for focusing attention on these very compounds was based on the following premises (1) cardiovascular disturbances influence the release of these peptides (2) they regulate vascular tone and cardiac function and can influence the intensity of ischemia - the factor initiating pain signals in the cardiovascular system, (3) they differentially modulate nociception through peripheral and central mechanisms, and their effect strongly depends on specific receptors and site of action. Accordingly, an altered release of these peptides and/or pharmacological blockade of their receptors may have a significant but different impact on individual sensation of pain and comfort of an individual patient.
Collapse
Affiliation(s)
- Ewa Szczepanska-Sadowska
- Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, Warsaw, Poland.
| | - Agnieszka Cudnoch-Jedrzejewska
- Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, Warsaw, Poland
| | - Bogdan Sadowski
- School of Engineering and Health, Bitwy Warszawskiej 1920 r. 18, Warsaw, Poland
| |
Collapse
|
3
|
Jiang WQ, Bao LL, Sun FJ, Liu XL, Yang J. Oxytocin in the periaqueductal gray mainly comes form the hypothalamic supraoptic nucleus to participate in pain modulation. Peptides 2019; 121:170153. [PMID: 31499086 DOI: 10.1016/j.peptides.2019.170153] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2019] [Revised: 08/31/2019] [Accepted: 09/06/2019] [Indexed: 10/26/2022]
Abstract
Oxytocin (OXT) that effects the nociception process is mainly synthesized and secreted in the hypothalamic supraoptic nucleus (SON). Although the periaqueductal gray (PAG) hardly synthesizes OXT, OXT in PAG also plays a role in pain regulation. The communication investigates whether OXT in the PAG comes from SON to influence pain modulation. RT-PCR was used to analyze OXT mRNA expression and radioimmunoassay to measure OXT concentration. The results showed that (1) pain stimulation enhanced OXT mRNA expression in the SON at 10 min (268.1 ± 39.2%, p < 0.001) and 20 min (135.4±37.9%, p < 0.05) treatment and did not change in the PAG; (2) OXT level increase in SON perfusion liquid during pain stimulation [236.7±22.1% at 10 min (p < 0.001), 223.1±12.4% at 20 min (p<0.001), 56.1 ± 15.7% at 30 min (p < 0.01) and 11.2±14.2% at 40 min] was earlier than that in PAG perfusion liquid [17.8±9.7% at 10 min, 375.6±35.1% at 20 min (p < 0.001), 123.2±17.7% at 30 min (p < 0.001) and 52.7±22.4% at 40 min (p < 0.05)]; (3) SON excitation (L-glutamate sodium microinjection) induced OXT level increase in PAG perfusion liquid in a dose-dependent manner; (4) the bilateral SON cauterization completely controlled and the right SON cauterization partly reversed the pain stimulation induced-OXT concentration increase in PAG perfusion liquid. The data suggested that OXT in PAG came from SON, which might influence the pain process.
Collapse
Affiliation(s)
- Wen-Quan Jiang
- The 988th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army (The 153rd Hospital of the Chinese People's Liberation Army), Zhengzhou, Henan, China
| | - Le-Le Bao
- The 988th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army (The 153rd Hospital of the Chinese People's Liberation Army), Zhengzhou, Henan, China
| | - Fang-Jie Sun
- Xinxiang Institute for New Medicine and Academician Workstation of Henan Province, Xinxiang, Henan, China
| | - Xi-Lin Liu
- Grade 2018, Department of Stomatology, Luohe Medical College, Luohe, Henan, China
| | - Jun Yang
- Xinxiang Institute for New Medicine and Academician Workstation of Henan Province, Xinxiang, Henan, China.
| |
Collapse
|
4
|
Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model. Exp Brain Res 2019; 237:2995-3010. [DOI: 10.1007/s00221-019-05651-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Accepted: 09/07/2019] [Indexed: 10/26/2022]
|
5
|
Pourzitaki C, Tsaousi G, Papazisis G, Kyrgidis A, Zacharis C, Kritis A, Malliou F, Kouvelas D. Fentanyl and naloxone effects on glutamate and GABA release rates from anterior hypothalamus in freely moving rats. Eur J Pharmacol 2018; 834:169-175. [DOI: 10.1016/j.ejphar.2018.07.029] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Revised: 07/12/2018] [Accepted: 07/18/2018] [Indexed: 11/28/2022]
|
6
|
Yang FJ, Ma L, Yang J, Zhu ZL, Wang CH. Intranasal Vasopressin Relieves Orthopedic Pain After Surgery. Pain Manag Nurs 2018; 20:126-132. [PMID: 30082217 DOI: 10.1016/j.pmn.2018.06.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2017] [Revised: 05/11/2018] [Accepted: 06/11/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND Orthopedic pain after surgery is very common and difficult to manage. Although intranasal arginine vasopressin (AVP) relieves headache (tension-type headache and migraine mostly), the effect of intranasal AVP on the orthopedic pain after surgery is unknown. AIMS This study investigated the effect of intranasal AVP on orthopedic pain after surgery in a randomized controlled trial with a double-blind design. PARTICIPANTS The study included 653 orthopedic patients and 661 health volunteers. METHODS Orthopedic pain was analyzed by the visual analogue scales (VAS) and AVP concentration was determined by radioimmunoassay. RESULTS (1) intranasal AVP decreased the VAS level in orthopedic patients 2-4 weeks after surgery in a dose-dependent manner; (2) the cerebrospinal fluid (CSF) AVP concentration in orthopedic patients after surgery was higher than that in the health volunteers (38.57 ± 6.11 pg/mL vs 11.74 ± 2.85 pg/mL, p < .01), but had no change in plasma (p > .05); (3) CSF AVP concentration increased significantly in orthopedic patients during 24 hours after the intranasal AVP (p < .05 or .01), which related with VAS level negatively (all p < .01); (4) during 24 hours, intranasal AVP did not influence not only plasma AVP concentration, but also blood pressure, heart rate, respiratory rate and body temperature in orthopedic patients. COUCLUSIONS The findings contribute valuable information that intranasal AVP can treat orthopedic pain after surgery, and AVP could be an option for pain relief by intranasal administration.
Collapse
Affiliation(s)
- Fu-Juan Yang
- Central Hospital of Xinxiang Medical University, Xinxiang, Henan, China
| | - Ling Ma
- Central Hospital of Xinxiang Medical University, Xinxiang, Henan, China
| | - Jun Yang
- Xinxiang Institute for New Medicine, Xinxing, Henan, China.
| | - Zhi-Ling Zhu
- Central Hospital of Xinxiang Medical University, Xinxiang, Henan, China
| | - Chang-Hong Wang
- The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
| |
Collapse
|
7
|
Jiang HB, Du AL, Luo HY, Yang J, Luo XQ, Ma RQ, Shi CH, Xu YM. Arginine vasopressin relates with spatial learning and memory in a mouse model of spinocerebellar ataxia type 3. Neuropeptides 2017; 65:83-89. [PMID: 28619276 DOI: 10.1016/j.npep.2017.06.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2016] [Revised: 06/02/2017] [Accepted: 06/04/2017] [Indexed: 12/29/2022]
Abstract
Spinocerebellar ataxia is an inherited neurodegenerative disorder that the most prevalent type is type 3 (SCA3). Arginine vasopressin (AVP) is released within the lateral septum for controlling the learning and memory. This communication studied the effect of AVP on the spatial learning and memory of SCA3 mice. The spatial learning and memory were analyzed by Morris water maze test (MWM), and AVP concentration was measured by radioimmunoassay. The results showed that (Alves et al., 2010) the swimming velocity, distance traveled and latency to the platform of MWM in SCA3 mice were reduced slower than those in WT mice over 4 training days (p<0.05, 0.01 or 0.001); (Antunes and Zimmerman, 1978) SCA3 mice showed a lower performance of spatial learning and memory of MWM during the fifth day (test day) compared to WT mice; (Bao et al., 2014) SCA3 mice had a decrease of AVP concentration in cerebral cortex (6.3±0.6pg/mg vs. 11.4±1.0pg/mg, p<0.01), hypothalamus (6.1±1.3ng/mg vs. 10.3±2.1ng/mg, p<0.05), hippocampus (3.2±0.5pg/mg vs. 5.2±1.0pg/mg, p<0.01) and cerebellum (4.7±0.9pg/mg vs. 8.3±1.1pg/mg, p<0.01), not in spinal cord, pituitary and serum; and (Barberies and Tribollet, 1996) intraventricular AVP could significantly quicken swimming velocity, cut down distance traveled and reduce latency to the platform of MWM in a dose-dependent manner, but intraventricular AVP receptor antagonist weakened the spatial learning and memory of MWM in SCA3 mice during the fifth day. The data suggested that AVP in the brain, not spinal cord and peripheral system of SCA3 mice related with the change of the spatial learning and memory of MWM.
Collapse
Affiliation(s)
- Hong-Bo Jiang
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
| | - Ai-Lin Du
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Henan Provincial Key Laboratory of Brain Research, Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang, Henan, China
| | - Hai-Yang Luo
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
| | - Jun Yang
- Xinxiang Institute for New Medicine, Xinxiang, Henan, China.
| | - Xiao-Qiu Luo
- Henan Provincial Key Laboratory of Brain Research, Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang, Henan, China
| | - Rui-Qing Ma
- Xinxiang Institute for New Medicine, Xinxiang, Henan, China
| | - Chang-He Shi
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
| | - Yu-Ming Xu
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
| |
Collapse
|
8
|
Zhao XY, Zhang QS, Yang J, Sun FJ, Wang DX, Wang CH, He WY. The role of arginine vasopressin in electroacupuncture treatment of primary sciatica in human. Neuropeptides 2015; 52:61-5. [PMID: 26142756 DOI: 10.1016/j.npep.2015.06.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Revised: 06/02/2015] [Accepted: 06/03/2015] [Indexed: 10/23/2022]
Abstract
It has been implicated that electroacupuncture can relieve the symptoms of sciatica with the increase of pain threshold in human, and arginine vasopressin (AVP) in the brain rather than the spinal cord and blood circulation participates in antinociception. Our previous study has proven that AVP in the brain played a role in the process of electroacupuncture analgesia in rat. The goal of the present study was to investigate the role of AVP in electroacupuncture in treating primary sciatica in human. The results showed that (1) AVP concentration of cerebrospinal fluid (CSF) (7.5 ± 2.5 pg/ml), not plasma (13.2 ± 4.2 pg/ml) in primary sciatica patients was lower than that in health volunteers (16.1 ± 3.8 pg/ml and 12.3 ± 3.4 pg/ml), although the osmotic pressure in CSF and plasma did not change; (2) electroacupuncture of the bilateral "Zusanli" points (St. 36) for 60 min relieved the pain sensation in primary sciatica patients; (3) electroacupuncture increased the AVP level of CSF, not plasma in primary sciatica patients; and (4) there was the positive correlation between the effect of electroacupuncture relieving the pain and the AVP level of CSF in the primary sciatica patients. The data suggested that central AVP, not peripheral AVP might improve the effect of electroacupuncture treatment of primary sciatica in human, i.e., central AVP might take part in the electroacupuncture relieving the pain sensation in primary sciatica patients.
Collapse
Affiliation(s)
- Xue-Yan Zhao
- Department of Neurology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China
| | - Qi-Shun Zhang
- Department of Neurology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China
| | - Jun Yang
- Standard Technological Co. Ltd. (Xinxiang Institute for New Medicine), Xinxiang, Henan 453003, China; Jiangsu Su Bei People's Hospital (Clinical College of Yangzhou University), Yangzhou, Jiangsu 225001, China; Xinjiang Nikanka Biological Co. Ltd., Hucheng, Yili, Xinjiang 835707, China.
| | - Fang-Jie Sun
- Xinjiang Nikanka Biological Co. Ltd., Hucheng, Yili, Xinjiang 835707, China
| | - Da-Xin Wang
- Jiangsu Su Bei People's Hospital (Clinical College of Yangzhou University), Yangzhou, Jiangsu 225001, China
| | - Chang-Hong Wang
- The Second Affiliated Hospital of Xinxiang Medical University (Henan Provincial Mental Hospital), Xinxiang, Henan 453002, China
| | - Wei-Ya He
- Department of Neurology, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China.
| |
Collapse
|
9
|
Milutinović-Smiljanić S, Šarenac O, Lozić-Djurić M, Murphy D, Japundžić-Žigon N. Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization. Br J Pharmacol 2014; 169:900-8. [PMID: 23488898 DOI: 10.1111/bph.12161] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2012] [Revised: 01/16/2013] [Accepted: 02/17/2013] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND AND PURPOSE It is well recognized that vasopressin modulates the neurogenic control of the circulation. Here, we report the central mechanisms by which vasopressin modulates cardiovascular response to stress induced by immobilization. EXPERIMENTAL APPROACH Experiments were performed in conscious male Wistar rats equipped with radiotelemetric device for continuous measurement of haemodynamic parameters: systolic and diastolic BP and heart rate (HR). The functioning of the spontaneous baro-receptor reflex (BRR) was evaluated using the sequence method and the following parameters were evaluated: BRR sensitivity (BRS) and BRR effectiveness index (BEI). KEY RESULTS Under baseline physiological conditions intracerebroventricular injection of 100 and 500 ng of selective non-peptide V1a or V1b or V2 receptor antagonist did not modify BP, HR and BRR. Rats exposed to 15 min long stress by immobilization exhibited increase of BP, HR, reduction of BRS and no change in BEI. Pretreatment of rats with V1a receptor antagonist did not modulate the BP, HR, BRS and BEI response to stress. Pretreatment of rats with V1b receptor and V2 receptor antagonist, at both doses, prevented BRR desensitization and tachycardia, but failed to modulate stress-induced hypertension. CONCLUSIONS AND IMPLICATIONS Vasopressin by the stimulation of central V1b- and V2-like receptors mediates stress-induced tachycardia and BRR desensitization. If these mechanisms are involved, BRR desensitization in heart failure and hypertension associated with poor outcome, they could be considered as novel targets for cardiovascular drug development.
Collapse
|
10
|
Abdallah K, Artola A, Monconduit L, Dallel R, Luccarini P. Bilateral descending hypothalamic projections to the spinal trigeminal nucleus caudalis in rats. PLoS One 2013; 8:e73022. [PMID: 23951340 PMCID: PMC3737186 DOI: 10.1371/journal.pone.0073022] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2013] [Accepted: 07/17/2013] [Indexed: 11/25/2022] Open
Abstract
Several lines of evidence suggest that the hypothalamus is involved in trigeminal pain processing. However, the organization of descending hypothalamic projections to the spinal trigeminal nucleus caudalis (Sp5C) remains poorly understood. Microinjections of the retrograde tracer, fluorogold (FG), into the Sp5C, in rats, reveal that five hypothalamic nuclei project to the Sp5C: the paraventricular nucleus, the lateral hypothalamic area, the perifornical hypothalamic area, the A11 nucleus and the retrochiasmatic area. Descending hypothalamic projections to the Sp5C are bilateral, except those from the paraventricular nucleus which exhibit a clear ipsilateral predominance. Moreover, the density of retrogradely FG-labeled neurons in the hypothalamus varies according to the dorso-ventral localization of the Sp5C injection site. There are much more labeled neurons after injections into the ventrolateral part of the Sp5C (where ophthalmic afferents project) than after injections into its dorsomedial or intermediate parts (where mandibular and maxillary afferents, respectively, project). These results demonstrate that the organization of descending hypothalamic projections to the spinal dorsal horn and Sp5C are different. Whereas the former are ipsilateral, the latter are bilateral. Moreover, hypothalamic projections to the Sp5C display somatotopy, suggesting that these projections are preferentially involved in the processing of meningeal and cutaneous inputs from the ophthalmic branch of the trigeminal nerve in rats. Therefore, our results suggest that the control of trigeminal and spinal dorsal horn processing of nociceptive information by hypothalamic neurons is different and raise the question of the role of bilateral, rather than unilateral, hypothalamic control.
Collapse
Affiliation(s)
- Khaled Abdallah
- Clermont Université, Université d’Auvergne, NEURO-DOL: Trigeminal Pain and Migraine, BP 10448, Clermont-Ferrand; Inserm, U1107, Clermont-Ferrand, France
| | - Alain Artola
- Clermont Université, Université d’Auvergne, NEURO-DOL: Trigeminal Pain and Migraine, BP 10448, Clermont-Ferrand; Inserm, U1107, Clermont-Ferrand, France
| | - Lénaic Monconduit
- Clermont Université, Université d’Auvergne, NEURO-DOL: Trigeminal Pain and Migraine, BP 10448, Clermont-Ferrand; Inserm, U1107, Clermont-Ferrand, France
| | - Radhouane Dallel
- Clermont Université, Université d’Auvergne, NEURO-DOL: Trigeminal Pain and Migraine, BP 10448, Clermont-Ferrand; Inserm, U1107, Clermont-Ferrand, France
- * E-mail: (RD) (PL)
| | - Philippe Luccarini
- Clermont Université, Université d’Auvergne, NEURO-DOL: Trigeminal Pain and Migraine, BP 10448, Clermont-Ferrand; Inserm, U1107, Clermont-Ferrand, France
- * E-mail: (RD) (PL)
| |
Collapse
|
11
|
Yang J, Lu L, Wang HC, Zhan HQ, Hai GF, Pan YJ, Lv QQ, Wang DX, Wu YQ, Li RR, Xue L, Wang XH, Deng XM, Liu XF, Qian YN, Deng ZK, Zhang ZJ, Zhan XH, Zhou XJ, Wang GL, Zhai JX, Wang JC. Effect of intranasal arginine vasopressin on human headache. Peptides 2012; 38:100-4. [PMID: 22963731 DOI: 10.1016/j.peptides.2012.07.029] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/10/2012] [Revised: 07/08/2012] [Accepted: 07/09/2012] [Indexed: 11/27/2022]
Abstract
Arginine vasopressin (AVP), a nonapeptide hormone of posterior pituitary, reaches the central nervous system from systemic blood circulation with a difficulty because of the blood-brain barrier (BBB). The interest has been expressed in the use of the nasal route for delivery of AVP to the brain directly, exploiting the olfactory pathway. Our previous study has demonstrated that AVP in the brain rather than the spinal cord and blood circulation plays an important role in rat pain modulation. For understanding the role of AVP on pain modulation in human, the communication tried to investigate the effect of intranasal AVP on human headache. The results showed that (1) AVP concentration in both plasma and cerebrospinal fluid (CSF) increased significantly in headache patients, who related with the headache level; (2) there was a positive relationship between plasma and CSF AVP concentration in headache patients; and (3) intranasal AVP could relieve the human headache in a dose-dependent manner. The data suggested that intranasal AVP, which was delivered to the brain through olfactory region, could treat human headache and AVP might be a potential drug of pain relief by intranasal administration.
Collapse
Affiliation(s)
- Jun Yang
- College of Pharmacy, Xinxiang Medical University, Xinxiang, Henan 453003, China.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Dorsal horn antinociception mediated by the paraventricular hypothalamic nucleus and locus coeruleous: A comparative study. Brain Res 2012; 1461:41-50. [DOI: 10.1016/j.brainres.2012.04.042] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Revised: 03/01/2012] [Accepted: 04/22/2012] [Indexed: 11/23/2022]
|
13
|
Analysis of transcriptional levels of the oxytocin receptor in different areas of the central nervous system and behaviors in high and low licking rats. Behav Brain Res 2012; 228:176-84. [DOI: 10.1016/j.bbr.2011.12.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2011] [Revised: 11/29/2011] [Accepted: 12/02/2011] [Indexed: 11/21/2022]
|
14
|
Yang J, Zhao Y, Pan Y, Lu G, Lu L, Wang D, Wang J. Acetylcholine participates in pain modulation by influencing endogenous opiate peptides in rat spinal cord. ACTA ACUST UNITED AC 2012. [DOI: 10.4236/wjns.2012.21003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
15
|
Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci 2011; 14:1569-73. [PMID: 22019732 PMCID: PMC3225498 DOI: 10.1038/nn.2941] [Citation(s) in RCA: 88] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2011] [Accepted: 08/17/2011] [Indexed: 12/16/2022]
Abstract
Quantitative trait locus mapping of chemical/inflammatory pain in the mouse identified the Avpr1a gene, encoding the vasopressin-1A receptor (V1AR), as responsible for strain-dependent pain sensitivity to formalin and capsaicin. A genetic association study in humans revealed the influence of a single nucleotide polymorphism (rs10877969) within AVPR1A on capsaicin pain levels, but only in male subjects reporting stress at the time of testing. The analgesic efficacy of the vasopressin analog, desmopressin, revealed a similar interaction between the drug and acute stress, as desmopressin inhibition of capsaicin pain was seen only in non-stressed subjects. Additional experiments in mice confirmed the male-specific interaction of V1AR and stress, leading to the conclusion that vasopressin activates endogenous analgesia mechanisms unless they have already been activated by stress. These findings represent the first explicit demonstration of analgesic efficacy depending on the emotional state of the recipient, and illustrate the heuristic power of a bench-to-bedside-to-bench translational strategy.
Collapse
|
16
|
Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography–tandem mass spectrometry assay. Anal Biochem 2011; 416:45-52. [DOI: 10.1016/j.ab.2011.04.041] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2011] [Revised: 04/28/2011] [Accepted: 04/29/2011] [Indexed: 01/08/2023]
|
17
|
Jorge-Mora T, Misa-Agustiño MJ, Rodríguez-González JA, Jorge-Barreiro FJ, Ares-Pena FJ, López-Martín E. The effects of single and repeated exposure to 2.45 GHz radiofrequency fields on c-Fos protein expression in the paraventricular nucleus of rat hypothalamus. Neurochem Res 2011; 36:2322-32. [PMID: 21818659 DOI: 10.1007/s11064-011-0557-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2011] [Revised: 07/18/2011] [Accepted: 07/20/2011] [Indexed: 11/26/2022]
Abstract
This study investigated the effects of microwave radiation on the PVN of the hypothalamus, extracted from rat brains. Expression of c-Fos was used to study the pattern of cellular activation in rats exposed once or repeatedly (ten times in 2 weeks) to 2.45 GHz radiation in a GTEM cell. The power intensities used were 3 and 12 W and the Finite Difference Time Domain calculation was used to determine the specific absorption rate (SAR). High SAR triggered an increase of the c-Fos marker 90 min or 24 h after radiation, and low SAR resulted in c-Fos counts higher than in control rats after 24 h. Repeated irradiation at 3 W increased cellular activation of PVN by more than 100% compared to animals subjected to acute irradiation and to repeated non-radiated repeated session control animals. The results suggest that PVN is sensitive to 2.45 GHz microwave radiation at non-thermal SAR levels.
Collapse
Affiliation(s)
- T Jorge-Mora
- Departamento de Ciencias Morfológicas, Facultad de Medicina, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | | | | | | | | | | |
Collapse
|
18
|
Zubrzycka M, Janecka A. Effect of tooth pulp and periaqueductal central gray electrical stimulation on β-endorphin release into the fluid perfusing the cerebral ventricles in rats. Brain Res 2011; 1405:15-22. [DOI: 10.1016/j.brainres.2011.06.030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2011] [Revised: 06/01/2011] [Accepted: 06/11/2011] [Indexed: 10/18/2022]
|
19
|
Yang J, Liang JY, Zhang XY, Qiu PY, Pan YJ, Li P, Zhang J, Hao F, Wang DX, Yan FL. Oxytocin, but not arginine vasopressin is involving in the antinociceptive role of hypothalamic supraoptic nucleus. Peptides 2011; 32:1042-6. [PMID: 21310203 DOI: 10.1016/j.peptides.2011.02.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/01/2011] [Revised: 02/01/2011] [Accepted: 02/01/2011] [Indexed: 11/27/2022]
Abstract
Our previous study has demonstrated that the hypothalamic supraoptic nucleus (SON) plays a role in pain modulation. Oxytocin (OXT) and arginine vasopressin (AVP) are the important hormones synthesized and secreted by the SON. The experiment was designed to investigate which hormone was relating with the antinociceptive role of the SON in the rat. The results showed that (1) microinjection of L-glutamate sodium into the SON increased OXT and AVP concentrations in the SON perfusion liquid, (2) pain stimulation induces OXT, but not AVP release in the SON, and (3) intraventricular injection (pre-treatment) with OXT antiserum could inhibit the pain threshold increase induced by SON injection of L-glutamate sodium, but administration of AVP antiserum did not influence the antinociceptive role of SON stimulation. The data suggested that the antinociceptive role of the SON relates to OXT rather than AVP.
Collapse
Affiliation(s)
- Jun Yang
- School of Pharmacy, Xinxiang Medical University, Xixiang, Henan 453003, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Yang J, Li P, Zhang XY, Zhang J, Hao F, Pan YJ, Lu GZ, Lu L, Wang DX, Wang G, Yan FL. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the caudate nucleus to participate in pain modulation. Peptides 2011; 32:71-4. [PMID: 20965220 DOI: 10.1016/j.peptides.2010.10.014] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2010] [Revised: 10/10/2010] [Accepted: 10/11/2010] [Indexed: 10/18/2022]
Abstract
Arginine vasopressin (AVP), which is synthesized and secreted in the hypothalamic paraventricular nucleus (PVN), is the most important bioactive substance in the pain modulation. Our pervious study had shown that AVP plays an important role in pain modulation in caudate nucleus (CdN). The experiment was designed to investigate the source of AVP in CdN by the nucleus push-pull perfusion and radioimmunoassay. The results showed that: (1) pain stimulation increased the AVP concentration in the CdN perfusion liquid, (2) PVN decreased the effect of pain stimulation which was stronger in both sides than in one side of PVN cauterization; and (3) L-glutamate sodium would excited the PVN neurons by the PVN microinjection that could increase the AVP concentration in the CdN perfusion liquid. The data suggested that AVP in the CdN might come from the PVN in the pain process, i.e., AVP in the PVN might be transferred to the CdN to participate in the pain modulation.
Collapse
Affiliation(s)
- Jun Yang
- School of Pharmacy, Xinxiang Medical University, Xixiang, Henan 453003, China.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Zhou XJ, Yang J, Yan FL, Wang DX, Li XY, Fan XQ, Hao F, Yan XQ, Li XP, Li H, Liu WY, Lin BC. Norepinephrine plays an important role in antinociceptive modulation of hypothalamic paraventricular nucleus in the rat. Int J Neurosci 2010; 120:428-38. [PMID: 20504214 DOI: 10.3109/00207450802333649] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Our previous study has proven that hypothalamic paraventricular nucleus (PVN) plays a role in antinociception. The effects of studied classical neurotransmitter on PVN antinociceptive modulation were investigated in the rat. The results showed: (1) Pain stimulation increased norepinephrine (NE), but not epinephrine, dopamine (DA), 3,4-dihydroxyphenylacetic acid (DA metabolic product), homovanilic acid (DA metabolic product), serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HT metabolic product), acetycholine (Ach), choline (Ach metabolic product), gamma-aminobutyric acid (GABA), and L-glutamate acid concentrations in the PVN perfusion liquid; (2) PVN stimulation with L-glutamate sodium, which excited local neurons only, did not influence the concentrations of the studied classical neurotransmitter and metabolic product in the PVN perfusion liquid; (3) Microinjection of NE, epinephrine, or L-glutamate sodium into the PVN elevated pain threshold, and local administration of GABA decreased pain threshold in a dose-dependent manner, but PVN administration of Ach, DA, or 5-HT did not change pain threshold; (4) Microinjection of phentolamine (alpha-receptor antagonist) or MK801 [NMDA-receptor antagonist] into the PVN reduced pain threshold, and local administration of bicuculline (GABA-receptor antagonist) raised pain threshold, but PVN administration of propranolol (beta-receptor antagonist), atropine (Muscarinic cholinergic receptor antagonist), 6-OH gallamine (Nicotinic cholinergic receptor antagonist), fluperidol (DA-receptor antagonist), or cyproheptadine (5-HT-receptor antagonist) did not alter pain threshold. The data suggested that endogenous NE, not epinephrine, 5-HT, Ach, GABA, and L-glutamate acid played an important role in the PVN antinociceptive modulation.
Collapse
Affiliation(s)
- Xi-Jian Zhou
- Wuxi 101 Hospital of People Liberty Army, Wuxi, Jiangsu, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Gerardo RP, Rosalinda MR, Guadalupe ML, Miguel CL. Oxytocin, but not vassopressin, modulates nociceptive responses in dorsal horn neurons. Neurosci Lett 2010; 476:32-5. [DOI: 10.1016/j.neulet.2010.03.076] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2010] [Revised: 03/26/2010] [Accepted: 03/30/2010] [Indexed: 12/31/2022]
|
23
|
Wang DX, Yang J, Gu ZX, Song CY, Liu WY, Zhang J, Li XP, Li H, Wang G, Song C, Lin BC. Arginine vasopressin induces rat caudate nucleus releasing acetylcholine to participate in pain modulation. Peptides 2010; 31:701-5. [PMID: 19948196 DOI: 10.1016/j.peptides.2009.11.027] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2009] [Revised: 11/08/2009] [Accepted: 11/10/2009] [Indexed: 12/14/2022]
Abstract
A lot of studies have pointed that acetylcholine (Ach), a classic neurotransmitter can regulate pain process in the caudate nucleus (CdN). Our previous report has proven that arginine vasopressin (AVP) effects on pain modulation in the CdN. The communication was designed to investigate the interaction between AVP and Ach in the rat CdN during the pain process. AVP concentration was determined by radioimmunoassay (RIA) and Ach concentration by high performance liquid chromatography (HPLC). The results showed that pain stimulation increased both AVP and Ach concentrations in the CdN perfusion liquid; AVP increased Ach concentration in the CdN perfusion liquid, while AVP receptor antagonist including d(CH(2))(5)Tyr(Me)AVP (V(1) receptor antagonist) and d(CH(2))(5)[D-Ile(2), Ile(4), Ala-NH(2)(9)]AVP (V(2) receptor antagonist) decreased Ach concentration in the CdN perfusion liquid. The data indicated that the analgesic effect of AVP might be involved in the Ach system in the CdN.
Collapse
Affiliation(s)
- Da-Xin Wang
- Clinical Medical College of Yangzhou University (Subei People's Hospital), Yangzhou, Jiangsu 225001, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Yang J, Yuan H, Liu W, Song C, Xu H, Wang G, Song C, Ni N, Yang D, Lin B. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the nucleus raphe magnus to participate in pain modulation. Peptides 2009; 30:1679-82. [PMID: 19520128 DOI: 10.1016/j.peptides.2009.05.026] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2009] [Revised: 05/29/2009] [Accepted: 05/30/2009] [Indexed: 11/16/2022]
Abstract
Hypothalamic paraventricular nucleus (PVN) is one of the main sources of arginine vasopressin (AVP) synthesis and secretion. AVP is the most important bioactive substance in PVN regulating pain process. Our previous study has pointed that pain stimulation induced AVP increase in the nucleus raphe magnus (NRM), which plays a role in pain modulation. The present study was designed to investigate the source of AVP in the rat NRM during pain process using the methods of nucleus push-pull perfusion and radioimmunoassay. The results showed that pain stimulation increased the AVP concentration in the NRM perfusion liquid, PVN cauterization inhibited the role that pain stimulation induced the increase of AVP concentration in the NRM perfusion liquid, and PVN microinjection of L-glutamate sodium, which excited the PVN neurons, could increase the AVP concentration in the NRM perfusion liquid. The data suggested that AVP in the PVN might be transferred to the NRM to participate in pain modulation.
Collapse
Affiliation(s)
- Jun Yang
- State Key Laboratory of New Technology for Pharmaceuticals, Jiangsu Provincial Institute for Novel Pharmaceuticals at Taizhou, Yangtze River Pharmaceutical Group, 1 Yangtze River South Road, Taizhou, Jiangsu, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Yang J, Yuan HF, Liu WY, Zhang XX, Feng JP, Ni N, Yang DW, Song CY, Xu HT, Wang G, Song C, Lin BC. Norepinephrine regulates arginine vasopressin secretion in hypothalamic paraventricular nucleus relating with pain modulation. Neuropeptides 2009; 43:259-65. [PMID: 19573913 DOI: 10.1016/j.npep.2009.06.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/01/2009] [Revised: 06/06/2009] [Accepted: 06/08/2009] [Indexed: 11/28/2022]
Abstract
Our previous study has pointed that arginine vasopressin (AVP) and norepinephrine (NA) are two most important bioactive substances that play a role in hypothalamic paraventricular nucleus (PVN) regulating pain process. The communication was designed to investigate the interaction between AVP and NA in the rat PVN during the pain process. We used the potassium iontophoresis inducing tail-flick to test the pain threshold, PVN push-pull perfusion to collect the samples, high performance chromatography (HPLC) to determine the NA concentration and radioimmunoassay (RIA) to measure the AVP concentration. The results showed that (1) pain stimulation increased both NA and AVP concentrations in the PVN perfusion liquid; (2) PVN administration of l-glutamate sodium increased AVP, not NA concentration in the PVN perfusion liquid; (3) AVP or d(CH(2))(5)Tyr(Et)DAVP (AVP-receptor antagonist) neither changed pain threshold, nor influenced NA concentration in the PVN perfusion liquid; (4) Microinjection of NA into PVN could increase pain threshold in a dose-dependent manner, while PVN administration with phentolamine (alpha-receptor antagonist), not propranolol (beta-receptor antagonist) decreased pain threshold; (5) Administration of NA increased AVP concentration, while phentolamine, not propranolol decreased AVP concentration in the PVN perfusion liquid. These data suggested that it is through alpha-receptor rather than beta-receptor, NA induced PVN secretion of AVP that was delivered to the related brain regions to participate in pain modulation.
Collapse
Affiliation(s)
- Jun Yang
- State Key Laboratory of New Technology for Pharmaceuticals, Jiangsu Provincial Institute for Novel Pharmaceuticals at Taizhou, Yangtze River Pharmaceutical Group, Taizhou, Jiangsu 225321, China.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Yang J, Yuan H, Chu J, Yang Y, Xu H, Wang G, Liu WY, Lin BC. Arginine vasopressin antinociception in the rat nucleus raphe magnus is involved in the endogenous opiate peptide and serotonin system. Peptides 2009; 30:1355-61. [PMID: 19540433 DOI: 10.1016/j.peptides.2009.03.014] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2009] [Revised: 03/21/2009] [Accepted: 03/23/2009] [Indexed: 10/21/2022]
Abstract
Arginine vasopressin (AVP) in the nucleus raphe magnus (NRM) has been implicated in antinociception. This communication was designed to investigate which neuropeptide and neurotransmitter are involved in AVP antinociception in the rat NRM. The results showed that (1) in the NRM perfuse liquid, pain stimulation could increase the concentrations of AVP, leucine-enkephalin (L-Ek), methionine-enkephalin (M-Ek), beta-endorphin (beta-Ep), serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), but not change the concentrations of dynorphinA(1-13) (DynA(1-13)), oxytocin, achetylcholine, choline, gamma-aminobutyric acid, glutamate, dopamine, 3,4-dihydroxyphenylacetic acid, homovanilic acid, norepinephrine and epinephrine; (2) in the NRM perfuse liquid, AVP increased the concentrations of L-Ek, M-Ek, beta-Ep, DynA(1-13), 5-HT and 5-HIAA, but did not change the concentrations of oxytocin and the other studied neurotransmitters; (3) AVP antinociception in the NRM was attenuated by cypoheptadine (a 5-HT-receptor antagonist) or naloxone (an opiate receptor antagonist), but was not influenced by the other studied receptor antagonists. The data suggested that AVP antinociception in the NRM might be involved in endogenous opiate peptide and 5-HT system.
Collapse
Affiliation(s)
- Jun Yang
- State Key Laboratory of New Technology for Pharmaceuticals, Jiangsu Provincial Institute for Novel Pharmaceuticals at Taizhou, Yangtze River Pharmaceutical Group, Taizhou, Jiangsu 225321, China.
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Yang J, Yang Y, Chu J, Wang G, Xu H, Liu WY, Wang CH, Lin BC. Endogenous opiate peptides in the spinal cord are involved in the analgesia of hypothalamic paraventricular nucleus in the rat. Peptides 2009; 30:740-4. [PMID: 19452637 DOI: 10.1016/j.peptides.2009.01.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Many studies have shown that hypothalamic paraventricular nucleus (PVN) plays a role in pain process, and endogenous opiate peptide system in the spinal cord is involved in nociception. This communication was designed to study the relationship between PVN and endogenous opiate system in the spinal cord in the rat. The results showed that in both the thoracic and the lumber spinal cord, microinjection of 100 ng L-glutamate sodium into PVN could increase leucine-enkephalin (L-Ek), beta-endorphin (beta-Ep), dynorphinA(1-13) (DynA(1-13)) concentrations and PVN cauterization decreased L-Ek and beta-Ep concentrations. Pretreatment of the spinal cord with 5 microg naloxone, an opiate receptor antagonist could partly reverse the analgesia induced by microinjection of 100 ng L-glutamate sodium into PVN. The data suggested that PVN analgesia might be involved in the endogenous opiate peptide system in the spinal cord independently.
Collapse
Affiliation(s)
- Jun Yang
- Jiangsu Research Institute for Novel Pharmaceuticals, Yangtze River Pharmaceutical Group, Taizhou, China.
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Yang J, Yang Y, Wang CH, Wang G, Xu H, Liu WY, Lin BC. Effect of arginine vasopressin on acupuncture analgesia in the rat. Peptides 2009; 30:241-7. [PMID: 19022309 DOI: 10.1016/j.peptides.2008.10.013] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2008] [Revised: 09/13/2008] [Accepted: 10/20/2008] [Indexed: 11/16/2022]
Abstract
Arginine vasopressin (AVP) has been proven to be involved in the process of pain regulation. This communication was designed to investigate the effect of AVP on acupuncture analgesia in the rat model. The results showed that intraventricular injection (icv) of AVP could enhance acupuncture analgesia in a dose-dependent manner, whereas icv of anti-AVP serum decreased acupuncture analgesia. However, neither intrathecal (ith) nor intravenous injection (iv) of AVP or anti-AVP serum could influence acupuncture analgesia. Electrical acupuncture of "Zusanli" points (St. 36) decreased AVP concentration in the hypothalamic paraventricular nucleus (PVN), and increased AVP concentration in the hypothalamic supraoptic nucleus (SON), periaqueductial gray (PAG), caudate nucleus (CdN) and raphe magnus nucleus (RMN), but did not change AVP concentration in the pituitary, spinal cord and plasma. The effect of AVP on acupuncture analgesia was partly reversed by pretreatment with naloxone, an opiate receptor antagonist. These data suggested that AVP in the brain played a role in the process of acupuncture analgesia in combination with the endogenous opiate peptide system.
Collapse
Affiliation(s)
- Jun Yang
- Jiangsu Institute (Taizhou) for New Medicines, Yangtze River Pharmaceutical Group, Taizhou, Jiangsu, China.
| | | | | | | | | | | | | |
Collapse
|
29
|
Karbiwnyk CM, Faul KC, Turnipseed SB, Andersen WC, Miller KE. Determination of oxytocin in a dilute IV solution by LC–MSn. J Pharm Biomed Anal 2008; 48:672-7. [DOI: 10.1016/j.jpba.2008.06.016] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2008] [Revised: 06/20/2008] [Accepted: 06/24/2008] [Indexed: 11/30/2022]
|
30
|
Condés-Lara M, Rojas-Piloni G, Martínez-Lorenzana G, López-Hidalgo M, Rodríguez-Jiménez J. Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells. Brain Res 2008; 1247:38-49. [PMID: 18996098 DOI: 10.1016/j.brainres.2008.10.030] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2008] [Revised: 10/02/2008] [Accepted: 10/05/2008] [Indexed: 11/18/2022]
Abstract
Recent results implicate a new original mechanism involving oxytocin (OT), as a mediator via descending fibers of the paraventricular hypothalamic nucleus (PVN), in antinociception and analgesia. In rats electrical stimulation of the PVN or topical application of OT selectively inhibits A-delta and C fiber responses in superficial dorsal horn neurons, and this inhibition is reversed by a selective OT antagonist. However, little is known about the mechanisms and the spinal elements participating in this phenomenon. Here we show that topical application of bicuculline blocks the effects produced by PVN electrical stimulation or OT application. PVN electrical stimulation also activates a subpopulation of neurons in lamina II. These PVN-On cells are responsible for the amplification of local GABAergic inhibition. This result reinforces the suggestion that a supraspinal descending control of pain processing uses a specific neuronal pathway in the spinal cord in order to produce antinociception involving a GABAergic interneuron. Moreover, the topical administration of naloxone or a mu-opiate receptor antagonist beta-funaltrexamine only partially blocks the inhibitory effects produced by OT application or PVN electrical stimulation. Thus, this OT mechanism only involves opiate participation to a minor extent. The OT-specific, endogenous descending pathway represents an interesting mechanism to resolve chronic pain problems in special the neuropathic pain.
Collapse
Affiliation(s)
- Miguel Condés-Lara
- Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM-Juriquilla, Querétaro 76230, Mexico.
| | | | | | | | | |
Collapse
|
31
|
Condés-Lara M, Martínez-Lorenzana G, Rodríguez-Jiménez J, Rojas-Piloni G. Paraventricular hypothalamic nucleus stimulation modulates nociceptive responses in dorsal horn wide dynamic range neurons. Neurosci Lett 2008; 444:199-202. [PMID: 18721859 DOI: 10.1016/j.neulet.2008.08.027] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2008] [Revised: 08/07/2008] [Accepted: 08/09/2008] [Indexed: 10/21/2022]
Abstract
Effects of different parameters of hypothalamic paraventricular nucleus (PVN) electrical stimulation on somatic responses, in dorsal horn neurons were examined. In anaesthetized rats, single-unit extracellular recordings were made from dorsal horn lumbar segments, which receive afferent input from the toe and hind paw regions. We compared the neuronal responses evoked by electrical stimulation of the receptive field (RF) with the responses preceded by ipsilateral PVN stimulation. Only the responses corresponding to Adelta and C-fiber activation were inhibited when PVN stimulation was delivered. Fast-evoked responses corresponding to Abeta fibers were not modified. The magnitude of inhibition depends on the intensity and duration of the PVN stimulation train and gradually decreases as the time interval between the PVN and RF stimulations increases. The results indicate that PVN modulates nociceptive, but not non-nociceptive neuronal responses at the spinal cord level, and this modulation depends on the parameters of the stimulus utilized to activate PVN neurons.
Collapse
Affiliation(s)
- Miguel Condés-Lara
- Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM-Juriquilla, Querétaro 76230, Mexico
| | | | | | | |
Collapse
|
32
|
Rojas-Piloni G, Martínez-Lorenzana G, DelaTorre S, Condés-Lara M. Nociceptive spinothalamic tract and postsynaptic dorsal column neurons are modulated by paraventricular hypothalamic activation. Eur J Neurosci 2008; 28:546-58. [DOI: 10.1111/j.1460-9568.2008.06366.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Pinto-Ribeiro F, Ansah OB, Almeida A, Pertovaara A. Influence of arthritis on descending modulation of nociception from the paraventricular nucleus of the hypothalamus. Brain Res 2008; 1197:63-75. [DOI: 10.1016/j.brainres.2007.12.038] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2007] [Revised: 12/12/2007] [Accepted: 12/12/2007] [Indexed: 01/22/2023]
|
34
|
Yang J, Yang Y, Chen JM, Liu WY, Lin BC. Effect of hypothalamic supraoptic nucleus on acupuncture analgesia in the rat. Brain Res Bull 2008; 75:681-6. [DOI: 10.1016/j.brainresbull.2007.11.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2007] [Revised: 11/04/2007] [Accepted: 11/05/2007] [Indexed: 11/26/2022]
|
35
|
Yang J, Yang Y, Chen JM, Liu WY, Lin BC. Investigating the role of the hypothalamic supraoptic nucleus in nociception in the rat. Life Sci 2008; 82:166-73. [DOI: 10.1016/j.lfs.2007.10.023] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2006] [Revised: 10/27/2007] [Accepted: 10/31/2007] [Indexed: 11/25/2022]
|
36
|
Yang J, Yang Y, Chen JM, Liu WY, Wang CH, Lin BC. Effect of oxytocin on acupuncture analgesia in the rat. Neuropeptides 2007; 41:285-92. [PMID: 17664006 DOI: 10.1016/j.npep.2007.05.004] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2007] [Revised: 05/28/2007] [Accepted: 05/28/2007] [Indexed: 11/25/2022]
Abstract
Oxytocin has been demonstrated to be involved in pain modulation. Acupuncture analgesia is a very useful clinical tool for pain relief, which has over 2500-year history in China. The present study investigated the role of oxytocin in acupuncture analgesia in the rat through oxytocin administration and measurement. Central administration of oxytocin (intraventricular injection or intrathecal injection) enhanced acupuncture analgesia, while central administration of anti-oxytocin serum weakened acupuncture analgesia in a dose-dependent manner. However, intravenous injection of oxytocin or anti-oxytocin serum did not influence acupuncture analgesia. Electrical acupuncture of "Zusanli" (St. 36) reduced oxytocin concentration in the hypothalamic supraoptic nucleus, and elevated oxytocin concentration in the hypothalamic suprachiasmatic nucleus, hypothalamic ventromedial nucleus, thalamic ventral nucleus, periaqueductal gray, raphe magnus nucleus, caudate nucleus, thoracic spinal cord and lumbar spinal cord, but did not alter oxytocin concentration in the hypothalamic paraventricular nucleus, anterior pituitary, posterior pituitary and plasma. The data suggested that oxytocin in central nervous system rather than in peripheral organs is involved in acupuncture analgesia.
Collapse
Affiliation(s)
- Jun Yang
- Institute for Pharmaceuticals and Medical Science, Guangdong Bangmin Pharmaceutical Co. Ltd., Jianghai Distract, Jiangmen, Guangdong 529080, China.
| | | | | | | | | | | |
Collapse
|
37
|
Mutig K, Paliege A, Kahl T, Jöns T, Müller-Esterl W, Bachmann S. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 2007; 293:F1166-77. [PMID: 17626156 DOI: 10.1152/ajprenal.00196.2007] [Citation(s) in RCA: 121] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
In renal epithelia, vasopressin influences salt and water transport, chiefly via vasopressin V(2) receptors (V(2)Rs) linked to adenylyl cyclase. A combination of vasopressin-induced effects along several distinct portions of the nephron and collecting duct system may help balance the net effects of antidiuresis in cortex and medulla. Previous studies of the intrarenal distribution of V(2)Rs have been inconclusive with respect to segment- and cell-type-related V(2)R expression. Our study therefore aimed to present a high-resolution analysis of V(2)R mRNA expression in rat, mouse, and human kidney epithelia, supplemented with immunohistochemical data. Cell types of the renal tubule were identified histochemically using specific markers. Pronounced V(2)R signal in thick ascending limb (TAL) was corroborated functionally; phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter type 2 (NKCC2) was established in cultured TAL cells from rabbit and in rats with diabetes insipidus that were treated with the V(2)R agonist desmopressin. We found solid expression of V(2)R mRNA in medullary TAL (MTAL), macula densa, connecting tubule, and cortical and medullary collecting duct and weaker expression in cortical TAL and distal convoluted tubule in all three species. Additional V(2)R immunostaining of kidneys and rabbit TAL cells confirmed our findings. In agreement with strong V(2)R expression in MTAL, kidneys from rats with diabetes insipidus and cultured TAL cells revealed sharp, selective increases in NKCC2 phosphorylation upon desmopressin treatment. Macula densa cells constitutively showed strong NKCC2 phosphorylation. Results suggest comparably significant effects of vasopressin-induced V(2)R signaling in MTAL and in connecting tubule/collecting duct principal cells across the three species. Strong V(2)R expression in macula densa may be related to tubulovascular signal transfer.
Collapse
Affiliation(s)
- K Mutig
- Department of Anatomy, Charité Universitätsmedizin, Berlin, Germany
| | | | | | | | | | | |
Collapse
|
38
|
Yang J, Yang Y, Xu HT, Chen JM, Liu WY, Lin BC. Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat. ACTA ACUST UNITED AC 2007; 142:29-36. [PMID: 17341433 DOI: 10.1016/j.regpep.2007.01.006] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2006] [Revised: 01/21/2007] [Accepted: 01/21/2007] [Indexed: 11/16/2022]
Abstract
Previous study has proven that microinjection of arginine vasopressin (AVP) into periaqueductal gray (PAG) raises the pain threshold, in which the antinociceptive effect of AVP can be reversed by PAG pretreatment with V2 rather than V1 or opiate receptor antagonist. The present work investigated the AVP effect on endogenous opiate peptides, oxytocin (OXT) and classical neurotransmitters in the rat PAG. The results showed that AVP elevated the concentrations of leucine-enkephalin (L-Ek), methionine-enkephalin (M-Ek) and beta-endorphin (beta-Ep), but did not change the concentrations of dynorphinA(1-13) (DynA(1-13)), OXT, classical neurotransmitters including achetylcholine (Ach), choline (Ch), serotonin (5-HT), gamma-aminobutyric acid (GABA), glutamate (Glu), dopamine (DA), norepinephrine (NE) and epinephrine (E), and their metabolic products in PAG perfusion liquid. Pain stimulation increased the concentrations of AVP, L-EK, M-Ek, beta-Ep, 5-HT and 5-HIAA (5-HT metabolic product), but did not influence the concentrations of DynA(1-13), OXT, the other classical neurotransmitters and their metabolic products. PAG pretreatment with naloxone - an opiate receptor antagonist completely attenuated the pain threshold increase induced by PAG administration of AVP, but local pretreatment of OXT or classical neurotransmitter receptor antagonist did not influence the pain threshold increase induced by PAG administration of AVP. The data suggested that AVP in PAG could induce the local release of enkephalin and endorphin rather than dynophin, OXT and classical neurotransmitters to participate in pain modulation.
Collapse
Affiliation(s)
- Jun Yang
- Institute for Pharmaceuticals and Medical Science, Guangdong Bangmin Pharmaceutical Co. Ltd., Jianghai Distract, Jiangmen, Guangdong, 529080 China.
| | | | | | | | | | | |
Collapse
|
39
|
Yang J, Yang Y, Chen JM, Xu HT, Liu WY, Wang CH, Lin BC. Arginine vasopressin is an important regulator in antinociceptive modulation of hypothalamic paraventricular nucleus in the rat. Neuropeptides 2007; 41:165-76. [PMID: 17316791 DOI: 10.1016/j.npep.2006.12.005] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2006] [Revised: 12/09/2006] [Accepted: 12/14/2006] [Indexed: 11/16/2022]
Abstract
Our previous study has proven that hypothalamic paraventricular nucleus (PVN) stimulation increases pain threshold and PVN cauterization decreases pain threshold. The studied neuropeptides in PVN were investigated to involve to pain modulation in the rat. The results showed that (1) intraventricular injection (icv) of anti-arginine vasopressin (AVP) serum completely reversed pain threshold increase induced by l-glutamate sodium (Glu) injection into the PVN, and local administration (icv) of anti-leucine-enkephalin (L-Ek) serum or anti-beta-endorphin (beta-Ep) serum partly attenuated pain threshold increase induced by Glu injection into the PVN, but pre-treatment of anti-oxytocin (OXT), dynorphinA(1-13) (DynA(1-13)), cholecystokinin-like peptide (CCK), neurotensin (NT), corticotrophin-releasing hormone (CRH), adrenocorticotrophin (ACTH), somatostatin (SST), prolactin-releasing hormone (PRH), angiotensinII (AngII), vasoactive intestinal polypeptide (VIP), melanotropin-releasing hormone (MRH), thyrotropin-releasing hormone (TRH), substance P (SP) or growth hormone-releasing hormone (GHRH) serum (icv) did not influence the analgesic effect of PVN administration with Glu; (2) PVN stimulation with Glu elevated the concentrations of AVP, OXT, CCK, NT, CRH, SST, PRH and DynA(1-13) in PVN perfusion liquid, and could not change the concentrations of L-Ek, beta-Ep, AngII, ACTH, VIP, MRH, TRH, SP and GHRH in PVN perfusion liquid; (3) Pain stimulation increased the concentrations of AVP, L-Ek, beta-Ep, DynA(1-13), CRH and ACTH in PVN perfusion liquid, and did not alter the concentrations of OXT, CCK, NT, SST, PRH, AngII, VIP, MRH, TRH, SP and GHRH in PVN perfusion liquid. The data suggested that AVP played a more important role than the other studied peptides (OXT, L-Ek, beta-Ep, DynA(1-13), CCK, NT, CRH, ACTH, SST, PRH, AngII, VIP, MRH, TRH, SP and GHRH) in PVN antinociceptive progress.
Collapse
Affiliation(s)
- Jun Yang
- Institute for Pharmaceuticals and Medical Science, Guangdong Bangmin Pharmaceutical Co. Ltd., Jianghai Distract, Jiangmen, Guangdong 529080, China.
| | | | | | | | | | | | | |
Collapse
|
40
|
Condés-Lara M, Martínez-Lorenzana G, Rojas-Piloni G, Rodríguez-Jiménez J. Branched oxytocinergic innervations from the paraventricular hypothalamic nuclei to superficial layers in the spinal cord. Brain Res 2007; 1160:20-9. [PMID: 17599811 DOI: 10.1016/j.brainres.2007.05.031] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2007] [Revised: 05/09/2007] [Accepted: 05/12/2007] [Indexed: 11/24/2022]
Abstract
The paraventricular nucleus (PVN) of the hypothalamus is an interesting structure with diverse functions due to its different neuronal populations, neurotransmitters, and projections to other central nervous system structures. The PVN is a primary source of oxytocin (OT) in the central nervous system. In fact, a direct PVN projection to the spinal cord has been demonstrated by retrograde and anterograde tracers, and more than the 50% of this projection is oxytocinergic. This OT descending projection is proposed to be an endogenous system that controls the nociceptive information arriving at the spinal cord. However, we have no information about the specific organization of the OT descending innervations to the different spinal cord segments. The aim of the present study was to determine whether the projecting PVN neurons arrive at cervical regions and then continue to lumbar regions. That is, we sought to establish if the OT projecting cells have a topic or a diffuse projection in order to obtain histological data to support the endogenous OT diffuse mechanism of analgesia described elsewhere. With this purpose in mind we combined the OT immunohistochemistry technique with retrograde neuronal tracers in the spinal cord. We applied Diamidino Yellow (DY) for the superficial dorsal horn cervical segments and True Blue (TB) for the lumbar segments. Data were collected from eight rats with well-placed injections. We only used the animals in which the tracer deposits were confined to superficial layers I and II of the dorsal horn. A mainly ipsilateral projection was observed, but stained neurons were also observed in the contralateral PVN. A large fraction of the stained PVN cells was doubled labeled but some were single labeled. Combining the retrograde tracer techniques and the OT detection procedure, we observed triple-labeled neurons. The present results demonstrate that PVN neurons send collaterals at least to the superficial cervical and lumbar segments of the dorsal horn of the spinal cord. Moreover, some of these stained cells use OT as a neurotransmitter. These results are of great relevance since they demonstrate that the PVN plays an important role in the somatosensorial system, and they support anatomic evidence of an endogenous mechanism involved in analgesia. Finally, we also describe median raphe nucleus double-labeled cells (DY+TB) signaling diffuse descending projections for this largely studied nucleus that are involved in endogenous analgesia.
Collapse
Affiliation(s)
- Miguel Condés-Lara
- Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM Juriquilla, México.
| | | | | | | |
Collapse
|
41
|
Yang J, Yang Y, Chen JM, Liu WY, Wang CH, Lin BC. Central oxytocin enhances antinociception in the rat. Peptides 2007; 28:1113-9. [PMID: 17420069 DOI: 10.1016/j.peptides.2007.03.003] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2007] [Revised: 03/03/2007] [Accepted: 03/06/2007] [Indexed: 10/23/2022]
Abstract
The study aimed to investigate the effect of oxytocin on antinociception in the rat. The pain threshold was elevated by oxytocin following intraventricular (icv) or intrathecal injection (ith), and reduced by anti-oxytocin serum (icv or ith). But the pain threshold was not altered by intravenous injection (iv) of oxytocin or anti-oxytocin serum. Pain stimulation induced oxytocin concentration decrease in the hypothalamic supraoptic nucleus, and increase in the locus coeruleus, raphe magnus nucleus, caudate nucleus and spinal cord, but no change in the hypothalamic paraventricular nucleus and plasma. The results indicated that central, not peripheral oxytocin could enhance antinociception.
Collapse
Affiliation(s)
- Jun Yang
- Institute for Pharmaceuticals and Medical Science, Guangdong Bangmin Pharmaceutical Co. Ltd., Jianghai Distract, Jiangmen, Guangdong 529080, China.
| | | | | | | | | | | |
Collapse
|
42
|
Molecular cloning of three types of arginine vasotocin receptor in the newt, Cynops pyrrhogaster. Gen Comp Endocrinol 2007; 151:252-8. [PMID: 17367790 DOI: 10.1016/j.ygcen.2007.02.002] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2006] [Revised: 01/30/2007] [Accepted: 02/02/2007] [Indexed: 11/30/2022]
Abstract
Three types of cDNA encoding the arginine vasotocin (AVT) receptors from the newt, Cynops pyrrhogaster were cloned and the gene expression of each receptor analyzed in the organs and tissues of the newt. The deduced amino acid sequence of one type of AVT receptor, consisting of 418 amino acid residues, showed a high degree of sequence identity with the mammalian arginine vasopressin (AVP) V1a receptors (61-68%). The second type of cDNA, encoding an amino acid sequence consisting of 367 amino acid residues, exhibited a relatively high sequence identity with mammalian AVP V2 receptors (50-51%). The third cDNA, encoding a sequence of 415 amino acid residues, possessed high sequence identity with mammalian AVP V3/V1b receptors (59-63%). Phylogenetic analysis revealed that the first, second and third types of receptor were close to mammalian AVP V1a, V2 and V3/V1b receptors, respectively, and RT-PCR using gene specific primers for each type of receptor indicated that the first and second types of receptor mRNA were expressed in various organs and tissues, including the circulatory, osmoregulatory, and reproductive organs of both male and female newts. In contrast, mRNA expression of the third cDNA was mainly detected in the brain and pituitary, and its expression pattern was distinctly different from that of the other two. We suggest that the first, second and third types of newt AVT receptor obtained in the present study are counterparts of mammalian AVP V1a, V2 and V3/V1b receptors, respectively.
Collapse
|
43
|
Yang J, Yang Y, Chen JM, Xu HT, Liu WY, Lin BC. Arginine vasopressin in periaqueductal gray, which relates to antinociception, comes from hypothalamic paraventricular nucleus in the rat. Neurosci Lett 2007; 412:154-8. [PMID: 17123712 DOI: 10.1016/j.neulet.2006.10.049] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2006] [Revised: 10/29/2006] [Accepted: 10/31/2006] [Indexed: 11/19/2022]
Abstract
Hypothalamic paraventricular nucleus (PVN) is a major source of arginine vasopressin (AVP). Our previous work has proven that: (1) pain stimulation enhances PVN synthesis and secretion of AVP; (2) AVP in periaqueductal gray (PAG) plays a role in antinociception; (3) pain stimulation increases AVP concentration in PAG tissue. The present study was to investigate AVP source in PAG during pain modulation of the rat. The results showed that: (1) pain stimulation elevated AVP concentration in both PVN and PAG perfusion liquid, in which the peak of AVP concentration in PVN perfusion liquid occurred earlier than that in PAG perfusion liquid; (2) PVN cauterization weakened pain stimulation-induced PAG releasing AVP, in which the inhibitive effect of bilateral PVN cauterization showed stronger than that of unilateral PVN cauterization; (3) microinjection of l-glutamate sodium into PVN, which excited local neurons, increased AVP concentration in PAG perfusion liquid in a dose-dependent manner. The data suggest that AVP in PAG, which relates with pain modulation, comes from PVN.
Collapse
Affiliation(s)
- Jun Yang
- Institute for Pharmaceuticals and Medical Science, Guangdong Bangmin Pharmaceutical Co. Ltd., Jianghai Distract, Jiangmen, Guangdong 529000, China.
| | | | | | | | | | | |
Collapse
|
44
|
Medullary control of nociceptive transmission: Reciprocal dual communication with the spinal cord. ACTA ACUST UNITED AC 2006. [DOI: 10.1016/j.ddmec.2006.09.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|